Which parts of care can become a product?

Forward's ambition was larger than making a doctor's office more convenient. In a November 2023 Fierce Healthcare interview, cofounder Adrian Aoun argued that hardware and software could carry more of the work of care and reach far more people. The company's CarePods made that proposition physical: self-service units placed where consumers already spent time. This was a founder's theory of scale, expressed in a concrete product, rather than simply a new booking interface for an unchanged clinic.

The decision followed years of operating technology-enabled clinics. Aoun told the publication that observations inside those clinics informed the development of individual health applications and that future investment would focus on CarePods. Crucially, he also said clinicians would review data and approve care plans. The intended system was not literally independent of doctors. The proposed shift was to change how their work was allocated. That detail matters when assessing what the technology was meant to replace and what responsibilities remained.

Contemporaneous coverage of the launch described a membership starting at $99 a month and deployments planned for malls, gyms, and offices. Forward presented diagnostic tools, scans, testing, and access to health information as part of the offer. These were product and deployment claims, not independent evidence of clinical effectiveness or sustainable utilization. A subscription price tells us what the company asked customers to pay. It does not tell us how often the equipment was used, how much support each encounter required, or whether people renewed.

In November 2024, Forward announced that it was closing its locations and canceling visits. Fierce Healthcare reproduced the company's notice that app access was ending and that a medical team would provide temporary transition support. This is the decisive outcome in the historical episode. It establishes the end of that operating service, but not a complete causal explanation. Public reporting did not supply an audited decomposition of the relative roles of costs, demand, funding, implementation, and clinical design.

The most useful lesson therefore starts by resisting a simple verdict that healthcare cannot be automated. Many discrete clinical tasks can be supported by machines. The harder question is how a collection of tasks becomes dependable care. Someone must recognize an exception, interpret an uncertain result, arrange a referral, and remain accountable when a person needs help outside the product's scope. Moving work into a device can change where those obligations arise without making them disappear.

There are also two different scaling tests. Technical replication asks whether another unit can perform the same function. Service replication asks whether each new location has sufficient demand, maintenance, supervision, escalation, and follow-through. A founder can succeed on the first test and still face difficulty on the second. An investor or buyer should request evidence for both. That is an interpretation of the design challenge, not a claim that any one of these factors independently explains Forward's closure.

A disciplined first move for a similar venture would define one limited use case, retain clear clinical ownership, and measure the entire journey through resolution. It would also plan for a service interruption before a crisis makes continuity urgent. Forward's story turns a futuristic object into a practical set of questions: what gets easier for the patient, what work remains backstage, and who carries the obligation if the company stops operating? The last question belongs in the design from the beginning, because patients experience a care relationship even when a company describes a product.

For a discussion tailored to your team, explore a workshop with Julien.